Debate: Are cluster headache and migraine distinct headache disorders?

Mohammad Al Mahdi Al-Karagholi; Kuan-Po Peng; Anja Sofie Petersen; Irene De Boer; Gisela M. Terwindt; Messoud Ashina

doi:10.1186/s10194-022-01504-x

Debate: Are cluster headache and migraine distinct headache disorders?

Mohammad Al Mahdi Al-Karagholi, Kuan-Po Peng, Anja Sofie Petersen, Irene De Boer, Gisela M. Terwindt, Messoud Ashina^*

^*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift › Review › peer review

17 Citationer (Scopus)

14 Downloads (Pure)

Abstract

Cluster headache and migraine are regarded as distinct primary headaches. While cluster headache and migraine differ in multiple aspects such as gender-related and headache specific features (e.g., attack duration and frequency), both show clinical similarities in trigger factors (e.g., alcohol) and treatment response (e.g., triptans). Here, we review the similarities and differences in anatomy and pathophysiology that underlie cluster headache and migraine, discuss whether cluster headache and migraine should indeed be considered as two distinct primary headaches, and propose recommendations for future studies. Graphical Abstract: Video recording of the debate held at the 1st International Conference on Advances in Migraine Sciences (ICAMS 2022, Copenhagen, Denmark) is available at https://www.youtube.com/watch?v=uUimmnDVTTE.[Figure not available: see fulltext.]

Originalsprog	Engelsk
Artikelnummer	151
Tidsskrift	Journal of Headache and Pain
Vol/bind	23
Antal sider	13
ISSN	1129-2369
DOI	https://doi.org/10.1186/s10194-022-01504-x
Status	Udgivet - 2022

Bibliografisk note

Funding Information:
MMK, KPP, ASP and IDB report no conflict of interest. GMT has received consulting fees and honoraria for lectures/presentations from Allergan, Eli Lily, Lundbeck, Novartis and Teva. Personal fees from AbbVie/Allergan, Amgen, Eli Lilly, Lundbeck, Novartis, Pfizer and Teva. MA participated in clinical trials as the principal investigator for AbbVie/Allergan, Amgen, Eli Lilly, Lundbeck, Novartis and Teva. MA received a research grant (institutional) from Lundbeck Foundation, Novo Nordisk Foundation, Novartis. MA has no ownership interest and does not own stocks of any pharmaceutical company. MA serves as associate editor of Cephalalgia, associate editor of the Journal of Headache and Pain, and associate editor of Brain.

Funding Information:
The Research Fund of Rigshospitalet (E-23327-04). The Lundbeck Foundation for supporting the study through the Professor Grant (R310–2018-3711).

Publisher Copyright:
© 2022, The Author(s).

Adgang til dokumentet

10.1186/s10194-022-01504-xLicens: CC BY

FulltextForlagets udgivne version, 2,52 MBLicens: CC BY

Citationsformater

@article{5054eaa54bd54f68846ea1f105e6f2e9,

title = "Debate: Are cluster headache and migraine distinct headache disorders?",

abstract = "Cluster headache and migraine are regarded as distinct primary headaches. While cluster headache and migraine differ in multiple aspects such as gender-related and headache specific features (e.g., attack duration and frequency), both show clinical similarities in trigger factors (e.g., alcohol) and treatment response (e.g., triptans). Here, we review the similarities and differences in anatomy and pathophysiology that underlie cluster headache and migraine, discuss whether cluster headache and migraine should indeed be considered as two distinct primary headaches, and propose recommendations for future studies. Graphical Abstract: Video recording of the debate held at the 1st International Conference on Advances in Migraine Sciences (ICAMS 2022, Copenhagen, Denmark) is available at https://www.youtube.com/watch?v=uUimmnDVTTE.[Figure not available: see fulltext.]",

keywords = "CGRP, Cranial autonomic symptoms, Nitric oxide, PACAP, Trigeminovascular system",

author = "Al-Karagholi, {Mohammad Al Mahdi} and Kuan-Po Peng and Petersen, {Anja Sofie} and {De Boer}, Irene and Terwindt, {Gisela M.} and Messoud Ashina",

note = "Publisher Copyright: {\textcopyright} 2022, The Author(s).",

year = "2022",

doi = "10.1186/s10194-022-01504-x",

language = "English",

volume = "23",

journal = "Journal of Headache and Pain",

issn = "1129-2369",

publisher = "SpringerOpen",

}

TY - JOUR

T1 - Debate

T2 - Are cluster headache and migraine distinct headache disorders?

AU - Al-Karagholi, Mohammad Al Mahdi

AU - Peng, Kuan-Po

AU - Petersen, Anja Sofie

AU - De Boer, Irene

AU - Terwindt, Gisela M.

AU - Ashina, Messoud

PY - 2022

Y1 - 2022

N2 - Cluster headache and migraine are regarded as distinct primary headaches. While cluster headache and migraine differ in multiple aspects such as gender-related and headache specific features (e.g., attack duration and frequency), both show clinical similarities in trigger factors (e.g., alcohol) and treatment response (e.g., triptans). Here, we review the similarities and differences in anatomy and pathophysiology that underlie cluster headache and migraine, discuss whether cluster headache and migraine should indeed be considered as two distinct primary headaches, and propose recommendations for future studies. Graphical Abstract: Video recording of the debate held at the 1st International Conference on Advances in Migraine Sciences (ICAMS 2022, Copenhagen, Denmark) is available at https://www.youtube.com/watch?v=uUimmnDVTTE.[Figure not available: see fulltext.]

AB - Cluster headache and migraine are regarded as distinct primary headaches. While cluster headache and migraine differ in multiple aspects such as gender-related and headache specific features (e.g., attack duration and frequency), both show clinical similarities in trigger factors (e.g., alcohol) and treatment response (e.g., triptans). Here, we review the similarities and differences in anatomy and pathophysiology that underlie cluster headache and migraine, discuss whether cluster headache and migraine should indeed be considered as two distinct primary headaches, and propose recommendations for future studies. Graphical Abstract: Video recording of the debate held at the 1st International Conference on Advances in Migraine Sciences (ICAMS 2022, Copenhagen, Denmark) is available at https://www.youtube.com/watch?v=uUimmnDVTTE.[Figure not available: see fulltext.]

KW - CGRP

KW - Cranial autonomic symptoms

KW - Nitric oxide

KW - PACAP

KW - Trigeminovascular system

U2 - 10.1186/s10194-022-01504-x

DO - 10.1186/s10194-022-01504-x

M3 - Review

C2 - 36447146

AN - SCOPUS:85142912385

SN - 1129-2369

VL - 23

JO - Journal of Headache and Pain

JF - Journal of Headache and Pain

M1 - 151

ER -